Cutler Group’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,600
Closed -$63K 4046
2023
Q3
$63K Buy
+7,600
New +$674K 0.01% 1366
2020
Q3
Sell
-43,200
Closed -$156K 5030
2020
Q2
$156K Buy
43,200
+41,000
+1,864% +$3.76M 0.01% 1013
2020
Q1
$122K Sell
2,200
-47,100
-96% -$4.29M 0.01% 1239
2019
Q4
$300K Buy
49,300
+45,500
+1,197% +$4.4M 0.02% 646
2019
Q3
$51K Buy
+3,800
New +$408K ﹤0.01% 1525
2018
Q4
Sell
-1,700
Closed -$20K 4335
2018
Q3
$20K Buy
+1,700
New +$345K ﹤0.01% 2233
2016
Q3
Sell
-5,400
Closed -$2K 7094
2016
Q2
$2K Sell
5,400
-5,500
-50% -$177K ﹤0.01% 5688
2016
Q1
$10K Buy
+10,900
New +$319K ﹤0.01% 4036

Other funds holding MED

Cutler Group's MED Position: Q4 2023 in Review

Cutler Group sold out of Medifast (MED) in Q4 2023, closing a stake of 4,000 shares — an estimated $299K sold.

Cutler Group first reported a position in MED in Q1 2016 and held it in 13 quarters. The position peaked at $1.02M in Q4 2019. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Cutler Group reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 4,000 Medifast shares in Q4 2023, an estimated $299K.
  • Cutler Group first reported a position in Medifast in Q1 2016 and held it in 13 quarters.
  • Cutler Group's Medifast position peaked at $1.02M in Q4 2019.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.